Medicine and Dentistry
Polycystic Ovary Syndrome
100%
Bone Density
66%
Placebo
47%
Postmenopause
44%
Osteolysis
41%
Bone Mass
38%
Alendronic Acid
33%
Prevalence
31%
Bone Turnover
30%
Glycon
28%
Uterine Artery Embolization
27%
Cohort Analysis
23%
Uterine Fibroid
19%
Postmenopause Osteoporosis
18%
Hyperandrogenism
18%
Biochemical Marker
17%
Systematic Review
16%
Osteocalcin
16%
Maturity Onset Diabetes of the Young
15%
Diethylstilbestrol
14%
Quality of Life
14%
Lumbar Spine
14%
Gestagen
14%
Insulin Resistance
14%
Body Mass Index
14%
Cross Sectional Study
14%
Obstetrics
14%
Hormone Therapy
12%
Case-Control Study
12%
Dual-Energy X-Ray Absorptiometry
12%
Oral Contraceptive Agent
12%
Estrogen Therapy
11%
Hormone Substitution
11%
Oral Contraceptive
11%
Contraceptive Agent
11%
Chorionic Gonadotropin
10%
Mifepristone
10%
Misoprostol
10%
Female Genital Tract Cancer
10%
Primary Ovarian Insufficiency
10%
Genital Injury
10%
Premenopause
10%
Androgen
10%
Breast Cancer
10%
Absorptiometry
9%
Urinary System
9%
Randomized Controlled Trial
9%
Odds Ratio
9%
Osteoporosis
9%
Clinical Trial
9%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
64%
Alendronic Acid
43%
Ovary Polycystic Disease
32%
Postmenopause Osteoporosis
30%
Biochemical Marker
30%
Diethylstilbestrol
26%
Osteocalcin
24%
Progestin
16%
Replacement Therapy
15%
Salcatonin
13%
Ibandronic Acid
11%
Cohort Study
11%
Cross-Sectional Study
11%
Metformin
10%
Chorionic Gonadotropin
10%
Mifepristone
10%
Misoprostol
10%
Hydrocortisone
10%
Alkaline Phosphatase
9%
Telopeptide
9%
Collagen Type 1
8%
Prevalence
8%
Transdermal
8%
Vagina Atrophy
7%
Bleeding
7%
Randomized Controlled Trial
7%
Endocrine Therapy
7%
Placebo-Controlled Study
6%
Breast Cancer
6%
Creatinine
6%
Levonorgestrel
6%
Bisphosphonic Acid Derivative
6%
Major Depression
6%
Enzyme-Linked Immunosorbent Assay
6%
Clinical Trial
6%
Fragility Fracture
6%
Adverse Event
5%
Non Insulin Dependent Diabetes Mellitus
5%
Oral Contraceptive
5%
Antiandrogen
5%
Comorbidity
5%
Oral Contraceptive Agent
5%
Tranexamic Acid
5%
Drug Utilization
5%
Iron Deficiency
5%
Infarction
5%
Iron Deficiency Anemia
5%
Stillbirth
5%
Microsphere
5%
Somatomedin B
5%
Biochemistry, Genetics and Molecular Biology
Bone Density
60%
Bone Mass
46%
Postmenopause
41%
Osteolysis
40%
Osteocalcin
30%
Bone Turnover
26%
Cohort Study
23%
Prevalence
22%
Insulin Resistance
15%
Fat Mass
15%
Body Mass
14%
Premenopause
13%
Blood Pressure
11%
Glucose Test
10%
Glucose Tolerance Test
10%
Randomized Controlled Trial
10%
Prolactin
10%
Body Composition
10%
Impaired Glucose Tolerance
9%
Cross Sectional Study
9%
Blood Level
8%
Triglyceride
7%
X Ray
6%
Prospective Study
6%
Muscle Strength
6%
Insulin-Like Growth Factor 2
5%
Insulin-Like Growth Factor 1
5%
Body Size
5%
C-Peptide
5%
Lipid Profile
5%
Bone Remodeling
5%
Cortisol
5%
Corticotropin-Releasing Hormone
5%
Comorbidity
5%
Bovine Somatotropin
5%
Growth Hormone
5%
Interleukin 6
5%
Type I Collagen
5%
